This result suggests that PKM2 activity is not influenced by p53 in high-grade astrocytoma, even though p53 is recognized as a major regulator of the cell cycle and apoptosis in this pathology. The gene discussed is PKM; the disease is astrocytoma (excluding glioblastoma).